Other substances

4E1RCat

An eukaryotic initiation factor inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

4E1RCat on PubChem

Synonyms

(E)-4-(3-((5-(4-Nitrophenyl)furan-2-yl)methylene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic acid; Benzoic acid, 4-[2,3-dihydro-3-[[5-(4-nitrophenyl)-2-furanyl]methylene]-2-oxo-5-phenyl-1H-pyrrol-1-yl]-

 

Structure image - 4E1RCat

C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(O3)C4=CC=C(C=C4)[N+](=O)[O-])/C(=O)N2C5=CC=C(C=C5)C(=O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations
Nucleocapsid protein Small molecule In silico 		in silico 3.22

Predicted to bind to the SARS-CoV-2 nucleocapsid (N) protein C-terminal domain.

 Nov/03/2020
Export (.csv)